Diagnosis involves a combination of clinical performance, imaging, laboratory testing, and pathological activation. The platform can assist in matching the needs of a team of nationally and internationally authoritative experts to provide accurate diagnosis and treatment regimens. Treatment and management of treatment regimens involving the Stanford V program typically include drug therapy, rehabilitation interventions, and regular follow-up to multiple-dimensional management.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumor diseases have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely regimens according to changes in disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of the HL-companied Stanford V program.
The platform serves a team of nationally and internationally authoritative experts in the field of blood tumor services in China, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.